Compare LAND & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAND | DCTH |
|---|---|---|
| Founded | 1997 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.0M | 289.2M |
| IPO Year | 2013 | N/A |
| Metric | LAND | DCTH |
|---|---|---|
| Price | $8.93 | $9.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.60 |
| AVG Volume (30 Days) | 470.7K | ★ 737.7K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $67,936,000.00 | ★ $79,603,000.00 |
| Revenue This Year | N/A | $131.97 |
| Revenue Next Year | $5.36 | $38.84 |
| P/E Ratio | ★ N/A | $288.65 |
| Revenue Growth | N/A | ★ 251.54 |
| 52 Week Low | $8.47 | $8.12 |
| 52 Week High | $11.93 | $18.23 |
| Indicator | LAND | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 54.32 |
| Support Level | $8.71 | $9.84 |
| Resistance Level | $9.28 | $10.28 |
| Average True Range (ATR) | 0.16 | 0.44 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 51.49 | 50.71 |
Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.